Related Experiment Video

Updated: Aug 25, 2025

Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy
12:24

Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy

Published on: September 29, 2016

7.1K

Targeting feedback activation of signaling transduction pathways to overcome drug resistance in cancer

Xuejian Wang1, Wenyan Jiang1, Yanmei Du1

  • 1School of Pharmacy, Weifang Medical University, Weifang, Shandong, China.

Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|October 17, 2022
PubMed

Insights

Cancer therapies can trigger feedback activation in signaling pathways like AKT and ERK, leading to drug resistance. Combination therapies targeting these pathways show promise in overcoming resistance and improving anti-tumor effects.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Aberrant signaling transduction is a key driver of tumorigenesis.
  • Targeting signaling pathways is a crucial anticancer strategy.
  • Adaptive drug resistance arises from feedback activation and crosstalk between signaling pathways, leading to therapeutic failure.

Purpose of the Study:

  • To review treatments causing feedback activation of key signaling pathways (AKT, ERK, STAT3, EGFR, FGFR, HER2/3).
  • To explore combination therapies for enhancing anti-tumor effects and overcoming drug resistance.
  • To investigate the molecular mechanisms underlying feedback activation and its regulation.

Main Methods:

  • Literature review of studies on signaling pathway feedback activation.
  • Analysis of combination therapies targeting these pathways.
  • Review of clinical trials evaluating combination treatments for cancer therapy.

Main Results:

  • Identified specific treatments that induce feedback activation in AKT, ERK, STAT3, EGFR, FGFR, and HER2/3 signaling.
  • Summarized combination strategies to counteract feedback activation and enhance anti-tumor efficacy.
  • Highlighted the role of specific proteins in regulating feedback mechanisms.

Conclusions:

  • Understanding feedback activation mechanisms is critical for developing effective cancer treatments.
  • Combination therapies offer a promising approach to overcome adaptive drug resistance.
  • Targeting feedback loops can improve the therapeutic efficacy of anticancer agents.
Keywords:
CancerDrug-resistanceFeedback activationSignaling transduction

More Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.3K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.7K

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
8.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.7K